← FDA DRUG APPROVALS

FDA ANDA · ANDA076992

CIPROFLOXACIN

Sponsor: BEDFORD LABS

APPLICATION
ANDA076992
TYPE
ANDA
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CIPROFLOXACINDiscontinued
CIPROFLOXACIN 400MG/40ML (10MG/ML) · INJECTABLE · INJECTION
CIPROFLOXACINDiscontinued
CIPROFLOXACIN 200MG/20ML (10MG/ML) · INJECTABLE · INJECTION

Approval history

2004-09-23Original — Letter ↗TA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →